Klin Farmakol Farm. 2012;26(1):14-17

Psychopharmacology is now sixty

Oldřich Vinař
Samostatná psychiatrická ambulance, Praha

The introduction of modern psychotropic drugs some sixty years ago changed psychiatric care dramatically. Psychotropic drugs enabled

psychotherapy to become easier available for patients with symptoms which had interfered with open verbal communication.

The research of the mechanisms of action of psychotropic drugs opened the way to investigate the brain functions and cohtributed to

the progress of neuroscience. In the last years the development of qualitatively new psychotropics slowed down. A progeress can be

expected especially in the introduction of biological methods of the treatment of drug dependence and in combining drug treatment

with new physical methods, such as repetitive transcranial magnetic stimulation (rTMS), vagus nerve stimulation (VNS) or deep brain

stimulation (DBS). These methods differ substantially from electroconvulsive treatment. The patient remains conscious, he remains in

verbal contact with the physician and their application is not disagreeable.

Keywords: psychotropic drugs, neurotransmitters, receptors, drug development

Published: April 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vinař O. Psychopharmacology is now sixty. Klin Farmakol Farm. 2012;26(1):14-17.
Download citation

References

  1. Mechelli A, Crinion JT, Noppeney U, O'Doherty J, Ashburner J, Frackowiak RS, Price CJ. Neurolinguistics: structural plasticity in the bilingual brain. Nature. 2004; 431(7010): 757. Go to original source... Go to PubMed...
  2. Autry AE, Kavalali ET, Adachi M, Nosyreva E, Na ES, Los MF, Monteggia LM. NMDA receptor blockade at rest triggers rapid behavioral antidepressnat responses. Nature 2011 DOI: 10.1038/nature 10130. Published online 15 June 2011.
  3. Jian-Dong Sun, Yan Liu, Yu-He Yuan, Jing Li, Nai-Hong Chen. Gap Junction Dysfunction in the Prefrontal Cortex Induces Depressive-Like Behaviors in Rats. Neuropsychopharmacology advance online publication 21 December 2011; doi: 10.1038/npp.2011.319. Go to original source... Go to PubMed...
  4. Vinař O, Molčan J, Náhunek K, Švestka J, Zapletálek M. Ritanserin in schizophrenic patients. Activ.Nerv.Super. 1989; 31: 107-109.
  5. Vinař O, Vinařová M. Klinické srovnání propazepinu VÚFB a imipraminu. Activ, Nerv. Super. 1961; 3: 228-229.
  6. Vinař O. Psychopharmacology Research Ward. Ten Years' Experience. Internat. Pharmacopsychiat. 1976; 11: 32-42. Go to original source...
  7. Lehmann HE. Problems of evaluation and classification in psychopharmacology. In: Votava Z, Horváth, M, Vinař, O (eds.). Psychopharmacological Methods. Pergamon Press. Oxford 1963: 276-280.
  8. Mohr P, Rodriguez M, Slavíčková A, Hanka J. Stimulační metody v léčbě deprese: využití vagové stimulace (VNS) a hluboké mozkové stimulace (DBS). Psychiatrie (Praha) 2011; 15: 130-139.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.